Search bioRxiv⌕ Search

bioRxiv · 10.1101/249599

The Innate Immune Response to Ischemic Injury: a Multiscale Modeling Perspective

Abstract

BackgroundCell death as a result of ischemic injury triggers powerful mechanisms regulated by germline-encoded Pattern Recognition Receptors (PRRs) with shared specificity that recognize invading pathogens and endogenous ligands released from dying cells, and as such are essential to human health. Alternatively, dysregulation of these mechanisms contributes to extreme inflammation, deleterious tissue damage and impaired healing in various diseases. The Toll-like receptors (TLRs) are a prototypical family of PRRs that may be powerful anti-inflammatory targets if agents can be designed that antagonize their harmful effects while preserving host defense functions. This requires an understanding of the complex interactions and consequences of targeting the TLR-mediated pathways as well as technologies to analyze and interpret these, which will then allow the simulation of perturbations targeting specific pathway components, predict potential outcomes and identify safe and effective therapeutic targets.\n\nResultsWe constructed a multiscale mathematical model that spans the tissue and intracellular scales, and captures the consequences of targeting various regulatory components of injury-induced TLR4 signal transduction on potential pro-inflammatory or pro-healing outcomes. We applied known interactions to simulate how inactivation of specific regulatory nodes affects dynamics in the context of injury and to predict phenotypes of potential therapeutic interventions. We propose rules to link model behavior to qualitative estimates of pro-inflammatory signal activation, macrophage infiltration, production of reactive oxygen species and resolution. We tested the validity of the model by assessing its ability to reproduce published data not used in its construction.\n\nConclusionsThese studies will enable us to form a conceptual framework focusing on TLR4-mediated ischemic repair to assess potential molecular targets that can be utilized therapeutically to improve efficacy and safety in treating ischemic/inflammatory injury.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Dimitrova, E., Caromile, L. A., Laubenbacher, R. C., Shapiro, L. H.. 2018-01-17. The Innate Immune Response to Ischemic Injury: a Multiscale Modeling Perspective. https://doi.org/10.1101/249599

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A three-factor model can explain symmetry breaking and the n-1 rule during X-chromosome inactivation

X-chromosome inactivation (XCI) is a mammalian gene regulatory process that via chromosome-scale transcriptional silencing, leaves active a single X chromosome per diploid genome complement. The mechanisms that enable cells to select the appropriate number of X chromosomes to inactivate while leaving others active remain unclear. We demonstrate that all known chromosomal counting scenarios during XCI can be accounted for by a three-factor mathematical model that includes (1) Xist, the long noncoding RNA (lncRNA) responsible for gene silencing during XCI in eutherians, (2) an X-linked transcriptional activator of Xist, and (3) the autosomally-encoded SPEN, an Xist RNA-binding protein that is essential for gene silencing during XCI. In our model, symmetry between active X chromosomes is broken by stochastic differences in the number of Xist molecules that associate with the X chromosomes at the onset of XCI. Subsequently, integrated positive and negative feedback loops amplify then propagate superstoichiometric assemblies of SPEN complexed with Xist on the inactive chromosome(s), and select for levels of X-linked activator that enable only one X chromosome per diploid genome complement to remain active. Thus, asymmetric propagation of the SPEN-Xist ribonucleoprotein complex may play an essential role in symmetry breaking and chromosomal counting during XCI, independently of or in concert with cis-acting networks of DNA regulatory elements. Our results also have conceptual implications for gene regulatory circuits on autosomes.

systems biology↗

stem.MAP: Identification of cell-type-specific protein complexes in mammalian embryonic stem cells.

Protein complexes carry out critical functions during development. Mapping cell-type-specific protein complexes in early embryogenesis is essential for uncovering the molecular mechanisms of embryonic development. We unfortunately currently lack a catalog of protein complexes specific for embryogenesis including embryonic stem cells. Here we develop a proteomics-based machine learning workflow to predict protein complexes present in mouse embryonic stem cells (mESC). Our method integrates data from a cell-type agnostic protein complex resource with co-fractionation mass spectrometry (CF-MS) experiments on mESC. Our resource, stem.MAP, identifies 3,986 complexes encompassing ~133,000 unique interactions, and 8,616 proteins. stem.MAP captures variant complexes critical for stem cell function including the PRC2, BAF and NuRD complexes. stem.MAP also discriminates mutually exclusive interactions specific to embryonic stem cells (e.g. Eif4ebp2 - Eif4e). Finally we observe 1,388 high confidence stem.MAP interactions found only in mESC CF-MS data, many with support from AlphaFold modeling and a gastruloid coregulation network. We make stem.MAP protein complexes available through our web resource: stem.proteincomplexes.org. We anticipate stem.MAP will be beneficial to the study of early development and we expect our proteomics-based machine learning workflow to be applicable to the creation of any context-specific protein interaction network.

systems biology↗

Coarse-graining genome-scale metabolic models for dynamic, multi-scale simulations of Pseudomonas aeruginosa in gel environments

Microbial communities are shaped by coupled interactions between microenvironment conditions and the intracellular adaptations that emerge in response external metabolic cues. For pathogenic microbes such as Pseudomonas aeruginosa, these interactions can rapidly generate heterogeneous sub-populations that exhibit adaptations for sustaining host infection and resisting antibiotic treatment. Technological strides in -omics data collection, combined with robust computational tools like genome-scale metabolic models (GEM) for predicting cellular metabolism, have yielded promising multi-scale depictions of microbial population development in simulated spatial environments. These multi-scale model simulations help establish and evaluate mechanistic contexts for how infection-enhancing behaviors might emerge in the population or be influenced by variable perturbations in the biological system. However, the number and rigorous tuning of parameters influencing the connections between intracellular-extracellular events pose barriers when shaping simulations to different in vitro systems of interest. In this work, we present a genome-scale, metabolism-informed continuum model (GEM-CM), a computational framework for coupling a reaction-diffusion model to a surrogate GEM representation that generates metabolic rate predictions informed by flux balance analysis outputs. A key feature of GEM-CM is its application of random forest regression, or ensembles, to coarse-grain the interface connecting the GEM and reaction-diffusion models down to a small set of input metabolites methodically chosen through the random forests evaluation of feature importance. To demonstrate GEM-CMs utility, we evaluated simulation predictions against P. aeruginosa PA14 populations radially propagating in low weight percentage agar gels. In addition to biomass growth, we simulated PA14 populations producing the cytotoxic secondary metabolite pyocyanin (PCN). GEM-CM could capture PA14 growth dynamics in agar gels when ensembles were provided with three carbon source inputs describing the simulated growth media. Bacterial motility parameters and the random forest ensemble allowed GEM-CM simulations to accurately predict spatial biomass distributions for PA14 populations over time and probe their PCN production dynamics. Ensembles also demonstrated robust performance for single gene knockout conditions with GEM-CM simulation accurately capturing the partial or total biomass and PCN inhibition observed in transposon mutant screenings. When evaluating transposon mutant population development, the GEM-CM framework additionally suggested that metH may be a promising target to inhibit the spatial propagation of PA14. This works proof-of-concept applications illustrated GEM-CM utility as an early stage multi-scale modeling tool for interrogating in vitro metabolic behavior in microbial populations.

systems biology↗